ADC Therapeutics S.A. (ADCT) Social Stream
ADC THERAPEUTICS SA (ADCT) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering ADC THERAPEUTICS SA.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-26 | 7 | $55 | $34 | $43.714 | $1.11 | 3838.2% |
| 2022-02-08 | 7 | $55 | $29 | $41.142 | $1.11 | 3606.49% |
| 2022-04-12 | 7 | $54 | $26 | $37.285 | $1.11 | 3259.01% |
| 2022-04-19 | 6 | $54 | $30 | $39 | $1.11 | 3413.51% |
| 2022-05-10 | 6 | $54 | $30 | $38 | $1.11 | 3323.42% |
| 2022-05-23 | 6 | $54 | $17 | $35.833 | $1.11 | 3128.2% |
| 2022-06-15 | 6 | $54 | $17 | $33 | $1.11 | 2872.97% |
| 2022-07-14 | 6 | $44 | $17 | $31.333 | $1.11 | 2722.79% |
| 2022-08-09 | 6 | $44 | $16 | $31.166 | $1.11 | 2707.75% |
| 2022-08-13 | 6 | $44 | $15 | $29 | $1.11 | 2512.61% |
| 2022-08-22 | 6 | $44 | $15 | $25 | $1.11 | 2152.25% |
| 2022-09-17 | 6 | $44 | $11 | $24 | $1.11 | 2062.16% |
| 2022-09-19 | 6 | $44 | $11 | $24.166 | $1.11 | 2077.12% |
| 2022-09-21 | 7 | $29 | $5 | $17.666 | $1.11 | 1491.53% |
| 2022-10-21 | 7 | $44 | $5 | $21.285 | $1.11 | 1817.57% |
| 2022-11-08 | 7 | $44 | $5 | $21.285 | $1.11 | 1817.57% |
| 2022-11-09 | 7 | $25 | $5 | $14.833 | $1.11 | 1236.31% |
| 2022-11-14 | 7 | $25 | $5 | $14.166 | $1.11 | 1176.22% |
| 2022-12-19 | 8 | $25 | $5 | $13.857 | $1.11 | 1148.38% |
| 2023-01-25 | 8 | $25 | $5 | $13.714 | $1.11 | 1135.5% |
| 2023-03-03 | 8 | $25 | $5 | $13.428 | $1.11 | 1109.73% |
| 2023-03-09 | 8 | $20 | $5 | $12.285 | $1.11 | 1006.76% |
| 2023-04-21 | 8 | $20 | $5 | $12.285 | $1.11 | 1006.76% |
| 2023-04-24 | 8 | $20 | $2 | $11.571 | $1.11 | 942.43% |
| 2023-05-09 | 8 | $20 | $2 | $12.666 | $1.11 | 1041.08% |
| 2023-05-16 | 8 | $20 | $2 | $9.857 | $1.11 | 788.02% |
| 2023-06-06 | 8 | $20 | $2 | $10.666 | $1.11 | 860.9% |
| 2023-07-11 | 8 | $17 | $2 | $9.333 | $1.11 | 740.81% |
| 2023-08-09 | 8 | $17 | $2 | $8.333 | $1.11 | 650.72% |
| 2023-09-11 | 8 | $17 | $2 | $8.166 | $1.11 | 635.68% |
| 2023-09-19 | 8 | $17 | $2 | $7.833 | $1.11 | 605.68% |
| 2023-10-17 | 7 | $17 | $1 | $8.8 | $1.11 | 692.79% |
| 2023-11-02 | 7 | $17 | $0.7 | $8.74 | $1.11 | 687.39% |
| 2023-11-13 | 7 | $17 | $0.7 | $8.74 | $1.11 | 687.39% |
| 2023-11-20 | 7 | $17 | $0.7 | $6.94 | $1.11 | 525.23% |
The Trend in the Analyst Price Target
Over the past 50 weeks, ADCT's average price target has gone down $6.92.
ADCT reports an average of 528.09% for its upside potential over the past 50 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-12-06 | 8 | 25 | 5 | 13.857 | 3.410 | 306.36% |
| 2022-12-19 | 8 | 25 | 5 | 13.857 | 3.040 | 355.82% |
| 2023-06-20 | 8 | 17 | 2 | 9.333 | 2.280 | 309.34% |
| 2023-09-11 | 8 | 17 | 2 | 8.166 | 1.040 | 685.19% |
| 2023-09-14 | 8 | 17 | 2 | 7.833 | 0.873 | 797.25% |
ADCT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.14 | 3 | 1 | 2 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
ADCT's average broker recommendation rating worsened by 0.85 over the prior 19 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, ADC THERAPEUTICS SA's upside potential (average analyst target price relative to current price) is higher than 3892.29% of them.
- To contextualize these metrics, consider that out of all US stocks, ADC THERAPEUTICS SA's variance in analysts' estimates is lower than -3554.97% of them.
- In terms of how ADC THERAPEUTICS SA fares relative to stocks in the mid market cap category, note that its average analyst price target is greater than 1059.18% of that group.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, ADC THERAPEUTICS SA's number of analysts covering the stock is higher than 1760.92% of them.
In the Pharmaceutical Products industry, AMTI, CERE, and NUVB are the three stocks most similar to ADC THERAPEUTICS SA regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for ADCT? Use POWR Ratings for clearer insight into price direction.